SONOMA PHARMACEUTICALS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.159 USD | -0.87% |
|
+6.00% | -11.86% |
Chart calendar Sonoma Pharmaceuticals, Inc.
affa4c70f48bf54e0673e8d05f8fa.HMcJ_wf7zSMTmtDoxzwK_LTWrYI28srqyVWVULO7qvI.ZotkhzLWlBRX_IS9rW1Lk_u3mLpMt5mBowPBMsDS878xnm-rV5SgWieolQ~776e72e3c009fb0649effd62932fabd8
Upcoming events on Sonoma Pharmaceuticals, Inc.
Past events on Sonoma Pharmaceuticals, Inc.
| 09/04/2024 20:00 | LD Micro Invitational Conference |
| 02/04/2024 22:44 | Trickle Research Spring Microcap Conference |
| 08/02/2024 21:15 | Q3 2024 Earnings Release |
| 13/11/2023 21:30 | Q2 2024 Earnings Release |
| 02/11/2023 | Symposium on Advanced Wound Care Fall Conference |
| 11/10/2023 | Dawson James Small Cap Growth Conference |
| 28/09/2023 21:00 | Annual General Meeting |
| 10/08/2023 21:15 | Q1 2024 Earnings Release |
| 22/06/2023 12:30 | Q4 2023 Earnings Release |
| 14/02/2023 21:30 | Q3 2023 Earnings Release |
| 02/02/2023 17:30 | Sequire Biotechnology Conference |
| 14/11/2022 21:15 | Interim 2023 Earnings Release |
| 31/10/2022 | CPHI Conference |
| 15/09/2022 21:00 | Annual General Meeting |
| 11/08/2022 21:30 | Q1 2023 Earnings Release |
| 13/07/2022 21:45 | FY 2022 Earnings Release |
| 11/02/2022 21:30 | Q3 2022 Earnings Release |
| 09/01/2022 | H.C. Wainwright BioConnect Conference |
| 15/11/2021 13:00 | Interim 2022 Earnings Release |
| 15/09/2021 21:00 | Annual General Meeting |
Annual results
| Fiscal Period | March | 2019 | 2023 | 2024 |
|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 19,0 19,4 -2.22% | 0,00 | 14,7 |
|
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -11,3 -11,6 2.95% | 0,00 | -4,61 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -11,3 -11,6 2.24% | 0,00 | -5,08 |
|
Net income Million USD | Released Forecast Spread | -11,8 -11,6 -1.71% | -5,15 | -5,08 |
|
EPS USD | Released Forecast Spread | -12,8 -12,8 0.39% | -1,52 | -0,89 |
| Announcement Date | 01/07/19 | 21/06/23 | - |
Quarterly results
| Fiscal Period | Marzo | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 |
|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 2,73 3,48 -21.52% | 3,14 3,76 -16.54% | 3,98 | 4,20 | 4,25 | 4,60 | 4,86 | |
|
EBIT Million USD | Released Forecast Spread | -1,21 -1,19 -1.51% | -0,84 -1,16 27.24% | -1,02 | -0,92 | -0,94 | -0,85 | -0,65 | |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -1,30 -1,28 -1.41% | -0,92 -1,25 26.16% | -1,11 | -0,96 | -0,98 | -0,89 | -0,69 | |
|
Net income Million USD | Released Forecast Spread | -1,42 | -1,48 -1,28 -15.94% | -0,87 -1,25 30.72% | -1,11 | -0,96 | -0,98 | -0,89 | -0,69 |
|
EPS USD | Released Forecast Spread | -0,29 | -0,29 -0,24 -20.83% | -0,08 -0,21 61.9% | -0,17 | -0,14 | -0,13 | -0,11 | -0,08 |
| Announcement Date | 10/08/23 | 13/11/23 | 08/02/24 | - | - | - | - | - |
More events
Past sector events for Sonoma Pharmaceuticals, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- SNOA Stock
- Calendar Sonoma Pharmaceuticals, Inc.
